Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitoxantrone liposome vs mitoxantrone in advanced recurrent or metastatic breast cancer
CTR20200091Phase 2Completed
- Sponsor
- CSPC Pharmaceutical Group
- Start
- Feb 2020
- Modality
- Small Molecules, Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of mitoxantrone-liposome in breast cancer, sponsored by CSPC Pharmaceutical Group. Started Feb 2020; status: completed.
02
Drugs
mitoxantrone-liposome
03
Conditions
breast cancer
Beyond the preview
Go deeper on CTR20200091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200091.